Douglas Dieterich, MD
Hepatology · New York, NYNPI 1225056070
Payments from drug & device makers
Across 914 payments — averaging $1218.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$540K
- E.r. Squibb & Sons, L.L.C.$125K
- Intercept Pharmaceuticals, Inc.$112K
- Eiger Biopharmaceuticals, Inc.$91K
- AbbVie$60K
- GSK$58K
- plus $128K from 23 others
Across 13 payments — averaging $167.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 546 | $540,027 |
| E.r. Squibb & Sons, L.L.C. | 6 | $124,923 |
| Intercept Pharmaceuticals, Inc. | 91 | $111,813 |
| Eiger Biopharmaceuticals, Inc. | 40 | $91,272 |
| AbbVie | 74 | $59,777 |
| GSK | 38 | $57,821 |
| Madrigal Pharmaceuticals | 32 | $49,802 |
| Dova Pharmaceuticals | 14 | $15,093 |
| Merck | 16 | $14,732 |
| Swedish Orphan Biovitrum AB | 3 | $10,175 |
| Ipsen Biopharmaceuticals, Inc | 8 | $8,630 |
| Novartis | 3 | $7,170 |
| Albireo Pharma, Inc. | 2 | $5,773 |
| Novo Nordisk | 3 | $4,274 |
| Mirum Pharmaceuticals, Inc. | 13 | $4,101 |
| Echosens North America, Inc. | 4 | $3,692 |
| Sanofi | 1 | $2,196 |
| AstraZeneca | 1 | $1,340 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $158 |
| Integra Lifesciences Corporation | 1 | $122 |
| Axogen | 1 | $119 |
| Pfizer | 2 | $116 |
| Mallinckrodt Hospital Products Inc. | 3 | $95 |
| Boston Scientific | 3 | $62 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Orphalan Inc | 1 | $20 |
| Shionogi Inc | 1 | $17 |
| Sirtex Medical Inc | 1 | $5 |
| Travere Therapeutics, Inc. | 3 | $2 |
How this compares
$1,113,351 in reported general payments places this provider in the 90th percentile of 29 hepatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hepatology in New York
- Robert BrownNew York$2.1M
- Howard WormanNew York$962K
- Arun JesudianNew York$876K
- Meena BansalNew York$868K
- Jennifer LeongNew York$379K
- Tatyana KushnerNew York$322K
- Albert MinNew York$284K
- Joseph OdinNew York$115K
- Russell RosenblattNew York$90K
- Thomas SchianoNew York$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.